Limitations of Using Outcomes in the Placebo Arm of a Clinical Trial of Benign Prostatic Hyperplasia to Quantify Those in the Community

Roberts, Rosebud O.; Lieber, Michael M.; Jacobson, Debra J.; Girman, Cynthia J.; Jacobsen, Steven J.
June 2005
Mayo Clinic Proceedings;Jun2005, Vol. 80 Issue 6, p759
Academic Journal
OBJECTIVES: To quantify potential biases that may occur when placebo arms of clinical trials are used to characterize the natural history of disease and to compare incidence rates of benign prostatic hyperplasia (BPH) outcomes in community-dwelling men with outcomes in the placebo arm of a clinical trial of BPH. SUBJECTS AND METHODS: White men aged 50 years or older at baseline were selected randomly from the Olmsted County, Minnesota, community in 1990 and were monitored biennially through 1996 for urologic outcomes. Symptom progression, acute urinary retention, and minimally invasive or surgical treatment of BPH were assessed from a validated questionnaire and a review of community medical records. Findings from the Olmsted County Study (N=1193) and a selected subcohort (n=238) were compared with those from the placebo arm of the Medical Therapy of Prostatic Symptoms trial (N=737). RESULTS: During more than 5088 person-years of follow-up (mean, 4.9 years) in the Olmsted County Study, incidence rates per 1000 person-years were 8.5 (95% confidence interval [CI], 6.4-11.2) for acute urinary retention, 97.1 (95% CI, 88.7-106.0) for symptom progression, 6.6 (95% CL, 4.8-9.0) for surgery or minimally invasive treatment, and 105.1(95% CI, 96.4-114.4) for any outcomes for all men. For those meeting trial inclusion criteria (selected subcohort, n=238), incidence rates were 18.3, 86.5, 16.8, and 109.4, respectively. By comparison, incidence rates per 1000 person-years for the placebo arm of the Medical Therapy of Prostatic Symptoms clinical trial for BPH (mean follow-up, 4.5 years) were 6 for acute urinary retention, 36 for symptom progression, and 45 for any outcome, but the estimate of 13 for surgery or minimally invasive treatment was higher than for men in the Olmsted County Study. CONCLUSIONS: Compared with community-dwelling men, men in the placebo arm of this clinical trial of BPH treatments had a substantially lower risk of BPH-related outcomes. Extrapolation of findings from the placebo arm of clinical trials to describe the natural history of disease in community-dwelling men should be done with caution and appropriate recognition of limitations.


Related Articles

  • Implementation of personalized self-management support using the self-management screening questionnaire SeMaS; a study protocol for a cluster randomized trial. Eikelenboom, Nathalie; van-Lieshout, Jan; Wensing, Michel; Smeele, Ivo; Jacobs, J. E. // Trials;2013, Vol. 14 Issue 1, p1 

    Background The number of patients with one or more chronic diseases is rising. In several standards of care there is a focus on enhancing self-management. We applied the concept of personalization on self-management support and developed a self-management screening questionnaire (SeMaS). The...

  • Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial. Tone Tangen Haug; Blomhoff, Svein; Hellstr∅m, Kerstin; Holme, Ingar; Humble, Mats; Madsbu, Hans Petter; Wold, Jan Egil // British Journal of Psychiatry;Apr2003, Vol. 182, p312 

    Background Maintenance of treatment effect is important for the choice of treatment for social phobia. Aims To examine the effect of exposure therapy end sertraline 28 weeks after cessation of medical treatment, Method In this study 375 patients with social phobia were randomised to treatment...

  • Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis. Kremer, Joel M.; Genant, Harry K.; Moreland, Larry W.; Russell, Anthony S.; Emery, Paul; Abud-Mendoza, Carlos; Szechinski, Jacek; Li, Tracy; Ge, Zhiyu; Becker, Jean-Claude; Westhovens, Rene // Annals of Internal Medicine;6/20/2006, Vol. 144 Issue 12, p865 

    Background: The selective co-stimulation modulator abatacept demonstrated efficacy for treating rheumatoid arthritis in early clinical studies. Objective: To evaluate the effects of abatacept in patients with persistent, active rheumatoid arthritis despite methotrexate treatment. Design:...

  • Randomized Controlled Trials on Treatment by Homeopaths and Self-Treatment with Homeopathic Medicines: Design and Protocol. Steinsbekk, Aslak; Bentzen, Niels; Fønnebø, Vinjar; Lewith, George T. // Journal of Alternative & Complementary Medicine;Dec2004, Vol. 10 Issue 6, p1027 

    This study investigates (1) whether treatment by homeopaths is more efficacious than self-selected conventional health care and (2) whether self-treatment with self-selected homeopathic medicines is more efficacious than placebo in preventing childhood upper respiratory tract infections...

  • How to use low-molecular-weight heparin to prevent DVT. Goldhaber, Samuel Z.; McRae, Simon J.; Wang, Jenny // Patient Care for the Nurse Practitioner;Apr2005, Vol. 8 Issue 4, p6 

    The article presents recommendations on how and when to use low-molecular-weight (LMWH) heparin to prevent deep-vein thrombosis (DVT). The American College of Chest Physicians guidelines for acute DVT treatment are outlined. If the patient is eligible for outpatient management and LMWH...

  • Topiramate for Migraine Prevention: A Randomized Controlled Trial. Brandes, Jan Lewis; Saper, Joel R.; Diamond, Merle; Couch, James R.; Lewis, Donald W.; Schmitt, Jennifer; Neto, Walter; Schwabe, Stefan; Jacobs, David // JAMA: Journal of the American Medical Association;2/25/2004, Vol. 291 Issue 8, p965 

    Context: Small open-label and controlled trials suggest that the antiepileptic drug topiramate is effective for migraine prevention. Objective: To assess the efficacy and safety of topiramate for migraine prevention in a large controlled trial. Design, Setting, and Patients: A 26-week,...

  • There Is Inadequate Evidence to Determine the Effectiveness of Nonpharmacological and Nonsurgical Interventions for Hand Osteoarthritis: An Overview of High-Quality Systematic Reviews. Moe, Rikke H.; Kjeken, Ingvild; Uhlig, Till; Hagen, Kåre Birger // Physical Therapy;Dec2009, Vol. 89 Issue 12, p1363 

    Background. Patients with hand osteoarthritis are commonly treated by health care professionals (allied to medicine). Practice should be informed by updated evidence from systematic reviews of randomized controlled trials. Purpose. The purpose of this overview is to summarize the evidence from...

  • Clinical process management with use of health information technology focusing on hospital information system. Tavakol, Ali; Hachesu, Peyman Rezaei; Rezapoor, Aziz; Rezazadeh, Esmaeil // HealthMed;2013, Vol. 7 Issue 6, p1728 

    Background: Healthcare organizations faced with coordination challenges. Use of Work Flow Management System (WFMS) is the suitable method for improving performance. Aim: In this article method of managing workflow for organizational and care process has studied separately. Suitable IT tools for...

  • Is there a place for placebo controlled trials of antiepileptic drugs? Shorvon, S.D.; Espir, M.L.E.; Steiner, T.J.; Dellaportas, C.I.; Rose, F. Clifford // British Medical Journal (Clinical Research Edition);11/9/1985, Vol. 291 Issue 6505, p1328 

    Examines the possibility of a placebo controlled trials on antiepileptic drugs in Great Britain. Uncertainty on the role of anticonvulsant drugs on epileptics; Impact of epileptic seizures on the psychology and social behavior of epileptics; Natural history of epilepsy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics